Opinion

Video

Looking Ahead: Future Landscape for Treating OFF Time and Dyskinesia

Author(s):

Daniel E. Kremens, MD, JD

An expert discusses D1 receptor agonists that reduce negative symptoms and the increasing availability of recent and upcoming PUMP options for Parkinson disease treatment.

Newsletter

Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.

Subscribe Now!
Related Videos
Esther Labib-Kiyarash, MSHA, CPHQ
Justin Martello, MD
William Ondo, MD
Jennifer Corcoran, MD
Marcia Pasqualini, PhD
Anissa Mitchell, LCSW
Daniel Irizarry, MD
Related Content
NeuroVoices: Cheryl Kyinn, PA-C, on Personalizing On-Demand Therapies for OFF Episodes in Parkinson Disease
July 2nd 2025

NeuroVoices: Cheryl Kyinn, PA-C, on Personalizing On-Demand Therapies for OFF Episodes in Parkinson Disease

Isabella Ciccone, MPH Cheryl Kyinn, PA-C
Multisymptomatic Care in Parkinson's Disease
September 4th 2024

Multisymptomatic Care in Parkinson's Disease

Stuart H. Isaacson, MD, FAAN Rajesh Pahwa, MD Jennifer G. Goldman, MD, MS
Daniel Irizarry, MD (Credit: LinkedIn)
June 28th 2025

Promoting Empathy, Exercise, and Effective Communication in Parkinson Disease Care

Isabella Ciccone, MPH Daniel Irizarry, MD
Sleeping Around the Podcast × NeurologyLive: Candidate Biomarkers to Detect REM Sleep Behavior Disorder in Parkinson Disease
April 9th 2024

Sleeping Around the Podcast × NeurologyLive: Candidate Biomarkers to Detect REM Sleep Behavior Disorder in Parkinson Disease

Anne Marie Morse, DO, FAASM NeurologyLive® Staff
Cynthia Fox, PhD, CCC-SLP (Credit: LinkedIn)
June 27th 2025

Reviewing Evidence-Based Rehabilitation for Voice and Movement in Parkinson Disease Care

Isabella Ciccone, MPH Cynthia Fox, PhD, CCC-SLP
Cuong Do, MBA (Credit: BioVie)
June 27th 2025

Phase 2 SUNRISE-PD Trial to Test BioVie‘s Bezisterim for Early-Stage Parkinson Disease

Isabella Ciccone, MPH
© 2025 MJH Life Sciences

All rights reserved.